fda details timeframe of ms drug tysabri's risks
the brain infection risk from biogen idec's multiple sclerosis drug tysabri appears highest during the third year of treatment, u.s. health officials said in an updated warning released on friday.
http://feeds.reuters.com/~r/reuters/healthnews/~3/qeo70fdvese/us-biogen-tysabri-idustre73l2wn20110422
4737
22 Apr 2011 20:48:54
reuters
health